Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]    
Revenue $ 33,272,000 $ 25,668,000
Cost of revenue 13,753,000 10,802,000
Gross profit 19,519,000 14,866,000
Operating expenses:    
Sales and marketing 16,220,000 11,736,000
Research and development 7,204,000 5,836,000
General and administrative 9,604,000 6,003,000
Total operating expenses 33,028,000 23,575,000
Loss from operations (13,509,000) (8,709,000)
Other income (expense):    
Interest expense (293,000) (280,000)
Other income (expense) (4,000) 6,000
Loss before income taxes (13,806,000) (8,983,000)
Provision for income taxes (32,000) 0
Net loss (13,838,000) (8,983,000)
Less: cumulative dividends on redeemable convertible preferred stock 0 (549,000)
Net loss attributable to common stock holders - basic (13,838,000) (9,532,000)
Net loss attributable to common stock holders - diluted $ (13,838,000) $ (9,532,000)
Net loss per share attributable to common stockholders - basic (in dollars per share) $ (0.21) $ (0.79)
Net loss per share attributable to common stockholders - diluted (in dollars per share) $ (0.21) $ (0.79)
Weighted-average common shares outstanding - basic (in shares) 64,583,714 12,035,941
Weighted-average common shares outstanding - diluted (in shares) 64,583,714 12,035,941